本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Wave Life Sciences Pte. Ltd

8.40
+0.01000.12%
盘后8.30-0.1000-1.19%17:55 EDT
成交量:139.75万
成交额:1,162.99万
市值:12.95亿
市盈率:-10.96
高:8.46
开:8.40
低:8.11
收:8.39
数据加载中...
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/03/26

重要事件披露

Form 8-K - Current report
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/04

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities